1. Home
  2. BLZE vs KPTI Comparison

BLZE vs KPTI Comparison

Compare BLZE & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Backblaze Inc.

BLZE

Backblaze Inc.

HOLD

Current Price

$7.40

Market Cap

218.8M

Sector

Technology

ML Signal

HOLD

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

HOLD

Current Price

$9.37

Market Cap

197.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLZE
KPTI
Founded
2007
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
218.8M
197.3M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
BLZE
KPTI
Price
$7.40
$9.37
Analyst Decision
Buy
Strong Buy
Analyst Count
6
7
Target Price
$7.60
$16.00
AVG Volume (30 Days)
459.7K
474.3K
Earning Date
05-04-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
58.56
N/A
EPS
N/A
N/A
Revenue
$145,835,000.00
$146,067,000.00
Revenue This Year
$10.16
N/A
Revenue Next Year
$10.91
$22.36
P/E Ratio
N/A
N/A
Revenue Growth
14.27
0.57
52 Week Low
$3.26
$3.65
52 Week High
$10.86
$10.99

Technical Indicators

Market Signals
Indicator
BLZE
KPTI
Relative Strength Index (RSI) 91.64 63.83
Support Level $7.35 $5.84
Resistance Level $8.16 $9.67
Average True Range (ATR) 0.27 0.60
MACD 0.26 0.04
Stochastic Oscillator 83.05 80.06

Price Performance

Historical Comparison
BLZE
KPTI

About BLZE Backblaze Inc.

Backblaze Inc offers a cloud storage platform designed to help businesses and consumers store, use, and protect their data. The company delivers its services through the Backblaze Storage Cloud platform, a purpose-built, web-scale software architecture operating on commodity hardware. Backblaze's offerings include B2 Cloud Storage, an Infrastructure-as-a-Service (IaaS) solution, and Computer Backup, a Software-as-a-Service (SaaS) solution. Its customer base includes individuals, developers, MSPs, small and medium-sized businesses, and large enterprises across industries, academic institutions, government agencies, and other enterprises. Geographically, the company generates maximum revenue from its business in the United States, followed by the United Kingdom, Canada, and other markets.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

Share on Social Networks: